Current through Register Vol. XLI, No. 50, December 13, 2024
Section 5-10-4 - General Rules for Practitioners for Patients Not Suffering from a Terminal Illness4.1. The provisions of this section only apply to a practitioner's prescribing, administering, or dispensing of Schedule II controlled substances, opioids, or benzodiazepines to a patient that the practitioner does not consider to be suffering from a terminal illness.4.2 A practitioner shall apply for and receive capability to access the CSMP before providing a patient any Schedule II controlled substance, any opioid, or any benzodiazepine.4.3. Before initially providing any Schedule II controlled substance, any opioid, or any benzodiazepine to a patient a current practitioner, or the practitioner's authorized agent, shall access the CSMP to determine whether the patient has obtained any controlled substance reported to the CSMP from any source other than the current practitioner within the 12 month period immediately preceding the current practitioner's encounter with the patient.4.4. The practitioner shall promptly document the initial CSMP data review in the patient's medical record. Documentation must include the date the practitioner accessed the patient's CSMP record, a dated copy of the CSMP report or a list of all controlled substances reported to the CSMP as dispensed to the patient within the preceding 12 months, and the practitioner's rationale for providing the patient Schedule II controlled substance(s), Opioid(s), and/or benzodiazepine(s).4.5. If a practitioner-patient relationship continues and the course of treatment includes the continued prescribing, dispensing or administering of any controlled substances, the practitioner shall access the CSMP at least annually to determine whether the patient has obtained any controlled substances reported to the CSMP from any source other than the current practitioner within the 12 month period immediately preceding the access. The access and any controlled substances from any other source other than the current practitioner reported to the CSMP within such 12 month immediately preceding the access shall be then promptly documented in the patient's medical record, with rationale for continuing to provide controlled substance by the current practitioner, with a copy of the CSMP accessed report signed and dated by the current practitioner.4.6. A practitioner may review a patient's CSMP data more frequently than annually. However, a practitioner must document each CSMP data review in the patient medical record. Documentation must include the date the practitioner accessed the patient's CSMP record, a dated copy of the CSMP report or a list of all controlled substances reported to the CSMP for the patient from any source other than the practitioner, and the practitioner's rationale for discontinuing or continuing to provide controlled substances to the patient.4.7. A practitioner who is providing a patient controlled substance medication shall review a patient's CSMP data whenever the provider has a specific concern regarding controlled substance abuse, misuse, or diversion of controlled substances by the patient.